Company · CIK 1479615
Silence Therapeutics plc
| CIK | 1479615 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | X0 |
| Listed | SLN (Nasdaq), SLNCF (OTC) |
| First annual or quarterly report | 2021-03-30 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-295992 | 2026-05-18 | 2026-08-12 | 5 | |
| 333-279185 | 2024-05-07 | 2024-05-14 | 2 | |
| 333-260265 | 2021-10-15 | 2022-08-12 | 4 | |
| 333-248203 | 2020-08-20 | 2021-10-20 | 8 | |
| 333-254021 | 2021-03-09 | 2021-10-20 | 6 |
Filings
26| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-12 | 424B5Shelf takedown | 333-295992 | 0001193125-26-347191 |
| 2026-08-10 | 424B5Shelf takedown | 333-295992 | 0001193125-26-342633 |
| 2026-05-27 | EFFECTDeclared effective | 333-295992 | 9999999995-26-001774 |
| 2026-05-27 | 424B5Shelf takedown | 333-295992 | 0001193125-26-242060 |
| 2026-05-18 | S-3Shelf registered | 333-295992 | 0001193125-26-228915 |
| 2024-05-14 | EFFECTDeclared effective | 333-279185 | 9999999995-24-001532 |
| 2024-05-07 | F-3Shelf registered | 333-279185 | 0001193125-24-133271 |
| 2022-08-12 | 424B5Shelf takedown | 333-260265 | 0001193125-22-219746 |
| 2021-10-22 | EFFECTDeclared effective | 333-260265 | 9999999995-21-004011 |
| 2021-10-22 | 424B5Shelf takedown | 333-260265 | 0001193125-21-305483 |
| 2021-10-20 | EFFECTDeclared effective | 333-254021 | 9999999995-21-003947 |
| 2021-10-20 | EFFECTDeclared effective | 333-248203 | 9999999995-21-003945 |
| 2021-10-15 | F-3Shelf registered | 333-260265 | 0001193125-21-299424 |
| 2021-04-12 | 424B4Final prospectus | 333-248203 | 0001193125-21-112725 |
| 2021-04-12 | 424B4Final prospectus | 333-254021 | 0001193125-21-112721 |
| 2021-04-08 | EFFECTDeclared effective | 333-254021 | 9999999995-21-001359 |
| 2021-04-08 | EFFECTDeclared effective | 333-248203 | 9999999995-21-001350 |
| 2021-03-12 | EFFECTDeclared effective | 333-254021 | 9999999995-21-000937 |
| 2021-03-11 | F-1/AAmendment | 333-254021 | 0000950123-21-003374 |
| 2021-03-09 | F-1Registration filed | 333-254021 | 0000950123-21-003321 |
| 2020-10-02 | EFFECTDeclared effective | 333-248203 | 9999999995-20-002725 |
| 2020-09-08 | 424B4Final prospectus | 333-248203 | 0001564590-20-042712 |
| 2020-09-04 | EFFECTDeclared effective | 333-248203 | 9999999995-20-002371 |
| 2020-08-26 | F-1/AAmendment | 333-248203 | 0000950123-20-009350 |
| 2020-08-20 | F-1Registration filed | 333-248203 | 0000950123-20-009257 |
| 2020-06-22 | DRSDraft made public | 377-03236 | 0001564590-20-030141 |